190 related articles for article (PubMed ID: 7721407)
1. 11 beta-Hydroxysteroid dehydrogenase and its inhibitors in hypertensive pregnancy.
Walker BR; Williamson PM; Brown MA; Honour JW; Edwards CR; Whitworth JA
Hypertension; 1995 Apr; 25(4 Pt 1):626-30. PubMed ID: 7721407
[TBL] [Abstract][Full Text] [Related]
2. Endogenous renal 11 beta-hydroxysteroid dehydrogenase inhibitory factors in patients with low-renin essential hypertension.
Takeda Y; Miyamori I; Iki K; Inaba S; Furukawa K; Hatakeyama H; Yoneda T; Takeda R
Hypertension; 1996 Feb; 27(2):197-201. PubMed ID: 8567041
[TBL] [Abstract][Full Text] [Related]
3. [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension].
Mosso L; Carvajal C; Campino C; Rojas A; González A; Barraza A; Montero J; Fardella C
Rev Med Chil; 2002 Nov; 130(11):1201-8. PubMed ID: 12587501
[TBL] [Abstract][Full Text] [Related]
4. Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension.
Walker BR; Stewart PM; Shackleton CH; Padfield PL; Edwards CR
Clin Endocrinol (Oxf); 1993 Aug; 39(2):221-7. PubMed ID: 8370136
[TBL] [Abstract][Full Text] [Related]
5. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH
J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270
[TBL] [Abstract][Full Text] [Related]
6. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart PM; Corrie JE; Shackleton CH; Edwards CR
J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
[TBL] [Abstract][Full Text] [Related]
7. 11 beta-Hydroxysteroid dehydrogenase deficit: a rare cause of arterial Hypertension. Diagnosis and therapeutic approach in two young brothers.
Gourmelen M; Saint-Jacques I; Morineau G; Soliman H; Julien R; Fiet J
Eur J Endocrinol; 1996 Aug; 135(2):238-44. PubMed ID: 8810740
[TBL] [Abstract][Full Text] [Related]
8. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
[TBL] [Abstract][Full Text] [Related]
9. Apparent mineralocorticoid excess.
Funder JW
Endocrinol Metab Clin North Am; 1995 Sep; 24(3):613-21. PubMed ID: 8575412
[TBL] [Abstract][Full Text] [Related]
10. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P
J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
[TBL] [Abstract][Full Text] [Related]
11. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
Ferrari P; Lovati E; Frey FJ
J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708
[TBL] [Abstract][Full Text] [Related]
12. Effect of glycyrrhetinic acid on 11 beta-hydroxysteroid dehydrogenase activity in normotensive and hypertensive subjects.
van Uum SH; Walker BR; Hermus AR; Sweep CG; Smits P; de Leeuw PW; Lenders JW
Clin Sci (Lond); 2002 Feb; 102(2):203-11. PubMed ID: 11834140
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.
Stewart PM; Wallace AM; Valentino R; Burt D; Shackleton CH; Edwards CR
Lancet; 1987 Oct; 2(8563):821-4. PubMed ID: 2889032
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man.
Walker BR; Connacher AA; Webb DJ; Edwards CR
Clin Sci (Lond); 1992 Aug; 83(2):171-8. PubMed ID: 1327632
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.
Walker BR; Andrew R; MacLeod KM; Padfield PL
Clin Endocrinol (Oxf); 1998 Aug; 49(2):257-63. PubMed ID: 9828916
[TBL] [Abstract][Full Text] [Related]
16. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine.
Heilmann P; Heide J; Hundertmark S; Schöneshöfer M
Exp Clin Endocrinol Diabetes; 1999; 107(6):370-8. PubMed ID: 10543414
[TBL] [Abstract][Full Text] [Related]
17. Short-term cortisol infusion in the brachial artery, with and without inhibiting 11 beta-hydroxysteroid dehydrogenase, does not alter forearm vascular resistance in normotensive and hypertensive subjects.
van Uum SH; Hermus AR; Sweep CG; Walker BR; Ross HA; de Leeuw PW; Lenders JW
Eur J Clin Invest; 2002 Dec; 32(12):874-81. PubMed ID: 12534445
[TBL] [Abstract][Full Text] [Related]
18. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
Rodríguez JA
Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
[TBL] [Abstract][Full Text] [Related]
19. Placental 11 beta-hydroxysteroid dehydrogenase activity in normotensive and pre-eclamptic pregnancies.
McCalla CO; Nacharaju VL; Muneyyirci-Delale O; Glasgow S; Feldman JG
Steroids; 1998 Oct; 63(10):511-5. PubMed ID: 9800281
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess.
Milford DV; Shackleton CH; Stewart PM
Clin Endocrinol (Oxf); 1995 Aug; 43(2):241-6. PubMed ID: 7554322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
